Market capitalization | $690.91m |
Enterprise Value | $814.53m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.04 |
P/S ratio (TTM) P/S ratio | 0.88 |
P/B ratio (TTM) P/B ratio | 1.31 |
Revenue growth (TTM) Revenue growth | 17.32% |
Revenue (TTM) Revenue | $784.25m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
4 Analysts have issued a Orthofix International NV forecast:
4 Analysts have issued a Orthofix International NV forecast:
Sep '24 |
+/-
%
|
||
Revenue | 784 784 |
17%
17%
|
|
Gross Profit | 516 516 |
22%
22%
|
|
EBITDA | -28 -28 |
68%
68%
|
EBIT (Operating Income) EBIT | -86 -86 |
36%
36%
|
Net Profit | -119 -119 |
13%
13%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Head office | Curaçao |
CEO | Massimo Calafiore |
Employees | 1,634 |
Founded | 1987 |
Website | www.orthofix.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.